Australia markets closed

Inspira Technologies Oxy B.H.N. Ltd. (IINN)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.9000-0.0500 (-2.56%)
At close: 04:00PM EDT
1.9800 +0.08 (+4.21%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.9500
Open1.9200
Bid1.8600 x 100
Ask1.9500 x 100
Day's range1.8350 - 1.9700
52-week range0.7610 - 2.4900
Volume90,736
Avg. volume202,023
Market cap33.013M
Beta (5Y monthly)2.20
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    Inspira™ Receives First Ever Purchase Order for INSPIRA™ ART100 Systems in the U.S.

    Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the "Company" or "Inspira"), a breakthrough medical technology company, today announced that is has received the first purchase order from Glo-Med Networks, Inc. ("Glo-Med") for its INSPIRA™ ART100 systems, with the five product units expected to be shipped in the fourth quarter of 2024. The purchase order also provides for the potential purchase of an additional 20 systems, the timing of which is subject to further agreement between I

  • PR Newswire

    Inspira™ to Exhibit the FDA Cleared INSPIRA™ ART100 System at a World-Renowned Event in the Sector

    Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a breakthrough medical technology company, is proud to announce plans to exhibit the INSPIRA™ ART100 System, recently cleared by the U.S. Food and Drug Administration ("FDA"), at the Extracorporeal Life Support Organization (ELSO) conference in Detroit, Michigan between September 29 to October 1, 2024.

  • PR Newswire

    Inspira™ Technologies Announces Business Targets Presentation Following FDA Clearance and Significant Developments

    Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the "Company" or "Inspira") a breakthrough medical technology company, announced today that Company President, Director, and co-founder, Mr. Joe Hayon, will discuss the Company's business targets, distribution agreements and next steps in a conference call to be held at 9:00am Eastern Time on Thursday, June 20, 2024. This follows the significant milestone of receiving FDA clearance for the INSPIRA™ ART100 system, as announced on May 28